Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Multani

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
MelanomaF G Haluska, P S Multani
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Monoclonal antibody-based therapies for hematologic malignanciesP S Multani, M L Grossbard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphomaP S Multani, S O'Day, L M Nadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphomaM L Grossbard, P S Multani, A S Freedman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
MelanomaF G Haluska, P S Multani
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Monoclonal antibody-based therapies for hematologic malignanciesP S Multani, M L Grossbard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphomaP S Multani, S O'Day, L M Nadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphomaM L Grossbard, P S Multani, A S Freedman, et al.
Pageof 1